Lotus Bio-Technology Development Corp. Updates Shareholders on CBD Initiatives
06 Settembre 2017 - 4:00PM
Access Wire
Company Prepares for Re-Entrance Into Medical
Marijuana Sector
HONG KONG / ACCESSWIRE / September 6, 2017 /
Lotus Bio-Technology Development Corp. (OTC PINK: LBTD) ("the
Company") is pleased to announce it will be undertaking previously
announced investments into CBD and Medical Cannabis product
development.
In November of 2016 the Company issued a press release detailing
its intentions of developing a CBD product line. The subsequent
resignation of the Company's former CEO in February of 2017
initially stalled those initiatives. With much of the previous
pipeline still in place, as well as stronger partnerships secured,
the company is ready to move forward aggressively to develop world
class CBD based products for the growing Medical Marijuana
sector.
The Company's strategic Chinese partnerships, such as Hunan
Cangshi, a successful proprietor, developer, and producer of
consumer related organic products, Phyto Nutraceutical Inc., a
developer, manufacturer, exporter, and primary supplier of plant
extracts and Changsha Huakang Biotechnology Development Co., Ltd,
which specializes in extracting active ingredients of natural herbs
and plants, places Lotus Bio-Tech in unique position to procure and
develop high quality products and compete for significant market
share in the Cannabis Industry.
The company will also be seeking U.S.-based strategic
partnerships to help facilitate with its end user supply chain for
new products as well as to explore additional opportunities within
the Medical Marijuana space.
About Lotus Bio-Technology Corp:
Lotus Bio-Technology is actively seeking new opportunities in
the emerging bio-natural industry in China. Our mandate is to
partner with companies that are in the organic growth sector that
meet the criteria we have set out to grow various plants under
strict organic standards. Plants that can be refined into various
products which are completely natural and strike a balance between
affordability while being produced from an environmentally
responsible manner. Products that are void of pesticides, synthetic
fertilizers, antibiotics, growth hormones and any other dangerous
chemicals. The Company has offices in China and Cave Creek, Arizona
USA.
Cautionary Note Regarding Forward-Looking
Statements:
This news release contains forward-looking statements about our
business or financial condition and prospects that reflect our
assumptions and beliefs based on information currently available.
We can give no assurance that the expectations indicated by such
forward-looking statements will be realized. There may be other
risks and circumstances that we are unable to predict. When used in
this news release, words such as "believes," "expects," "intends,"
"plans," "anticipates," "estimates," and similar expressions are
intended to identify forward-looking statements, although there may
be certain forward-looking statements not accompanied by such
expressions. Investors should not place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. The company's actual results could differ materially
from those anticipated in these forward-looking statements as a
result of a variety of factors, including risks discussed in the
company's periodic reports that are filed with the Securities and
Exchange Commission and available on its website (www.sec.gov). All
forward-looking statements attributable to the Company or to
persons acting on its behalf are expressly qualified in their
entirety by these factors other than as required under the
securities laws. The Company does not assume a duty to update these
forward-looking statements.
SOURCE: Lotus Bio-Technology Development
Corp.
Grafico Azioni Lotus Bio Technology Dev... (CE) (USOTC:LBTD)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Lotus Bio Technology Dev... (CE) (USOTC:LBTD)
Storico
Da Gen 2024 a Gen 2025
